A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Information source: Hoffmann-La Roche
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Post-Menopausal Osteoporosis
Intervention: ibandronate [Bonviva/Boniva] (Drug)
Phase: Phase 4
Status: Active, not recruiting
Sponsored by: Hoffmann-La Roche Official(s) and/or principal investigator(s): Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche, +1 973 235 5000
Summary
This single arm study will assess the efficacy and safety of quarterly intravenous Bonviva in
women with post-menopausal osteoporosis. All patients will receive Bonviva 3mg i. v. every 3
months. The anticipated time on study treatment is 3-12 months, and the target sample size is
100 individuals.
Clinical Details
Official title: An Open Label Study to Evaluate the Effect on Bone Mineral Density, and the Safety, of Quarterly Intravenous Bonviva in Patients With Post-Menopausal Osteoporosis.
Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Primary outcome: Mean change (%) in spinal BMD
Secondary outcome: Mean change in hip BMDMean change in Serum CTX Mean change in hip and spinal BMD AEs and clinical fractures Percentage change from baseline in OPSAT-Q
Eligibility
Minimum age: N/A.
Maximum age: 80 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- post-menopausal women with osteoporosis;
- <=80 years of age;
- naive to oral bisphosphonates, or have discontinued daily and/or weekly bisphosphonate
treatment for >1 year.
Exclusion Criteria:
- metabolic bone disease other than post-menopausal osteoporosis;
- treatment with other drugs affecting bone metabolism within last 6 months;
- previous or current malignant disease (except for adequately treated cancer in situ of
the cervix, or basal or squamous cell skin cancer).
Locations and Contacts
TAIPEI 100, Taiwan
TAIPEI 112, Taiwan
TAICHUNG 404, Taiwan
TAINAN 704, Taiwan
TAOYUAN 333, Taiwan
TAIPEI 886, Taiwan
TAICHUNG 407, Taiwan
TAICHUNG 402, Taiwan
CHANGHUA 500, Taiwan
KAOHSIUNG 807, Taiwan
KAOHSIUNG 833, Taiwan
TAINAN 710, Taiwan
CHAI YI 613, Taiwan
KAOHSIUNG 804, Taiwan
Additional Information
Starting date: June 2007
Ending date: October 2008
Last updated: June 17, 2008
|